28203094|t|Mapping circulating serum miRNAs to their immune - related target mRNAs
28203094|a|Evidence suggests that circulating serum microRNAs (miRNAs) might preferentially target immune - related mRNAs. If this were the case, we hypothesized that immune - related mRNAs would have more predicted serum miRNA binding sites than other mRNAs and, reciprocally, that serum miRNAs would have more immune - related mRNA targets than non - serum miRNAs. We developed a consensus target predictor using the random forest framework and calculated the number of predicted miRNA - mRNA interactions in various subsets of miRNAs (serum, non - serum) and mRNAs (immune related, nonimmune related). Immune - related mRNAs were predicted to be targeted by serum miRNA more than other mRNAs. Moreover, serum miRNAs were predicted to target many more immune - related mRNA targets than non - serum miRNAs; however, these two biases in immune - related mRNAs and serum miRNAs appear to be completely independent. Immune - related mRNAs have more miRNA binding sites in general, not just for serum miRNAs; likewise, serum miRNAs target many more mRNAs than non - serum miRNAs overall, regardless of whether they are immune related or not. Nevertheless, these two independent phenomena result in a significantly larger number of predicted serum miRNA - immune mRNA interactions than would be expected by chance.
28203094	20	25	serum	T031	UMLS:C0229671
28203094	26	32	miRNAs	T103	UMLS:C1101610
28203094	66	71	mRNAs	T103	UMLS:C0035696
28203094	107	112	serum	T031	UMLS:C0229671
28203094	113	122	microRNAs	T103	UMLS:C1101610
28203094	124	130	miRNAs	T103	UMLS:C1101610
28203094	177	182	mRNAs	T103	UMLS:C0035696
28203094	245	250	mRNAs	T103	UMLS:C0035696
28203094	277	282	serum	T031	UMLS:C0229671
28203094	283	296	miRNA binding	T038	UMLS:C1523647
28203094	297	302	sites	T082	UMLS:C0205145
28203094	314	319	mRNAs	T103	UMLS:C0035696
28203094	344	349	serum	T031	UMLS:C0229671
28203094	350	356	miRNAs	T103	UMLS:C1101610
28203094	390	394	mRNA	T103	UMLS:C0035696
28203094	414	419	serum	T031	UMLS:C0229671
28203094	420	426	miRNAs	T103	UMLS:C1101610
28203094	543	548	miRNA	T103	UMLS:C1101610
28203094	551	555	mRNA	T103	UMLS:C0035696
28203094	556	568	interactions	T038	UMLS:C2753463
28203094	580	587	subsets	T170	UMLS:C1515021
28203094	591	597	miRNAs	T103	UMLS:C1101610
28203094	599	604	serum	T031	UMLS:C0229671
28203094	612	617	serum	T031	UMLS:C0229671
28203094	623	628	mRNAs	T103	UMLS:C0035696
28203094	683	688	mRNAs	T103	UMLS:C0035696
28203094	722	727	serum	T031	UMLS:C0229671
28203094	728	733	miRNA	T103	UMLS:C1101610
28203094	750	755	mRNAs	T103	UMLS:C0035696
28203094	767	772	serum	T031	UMLS:C0229671
28203094	773	779	miRNAs	T103	UMLS:C1101610
28203094	832	836	mRNA	T103	UMLS:C0035696
28203094	856	861	serum	T031	UMLS:C0229671
28203094	862	868	miRNAs	T103	UMLS:C1101610
28203094	916	921	mRNAs	T103	UMLS:C0035696
28203094	926	931	serum	T031	UMLS:C0229671
28203094	932	938	miRNAs	T103	UMLS:C1101610
28203094	993	998	mRNAs	T103	UMLS:C0035696
28203094	1009	1022	miRNA binding	T038	UMLS:C1523647
28203094	1023	1028	sites	T082	UMLS:C0205145
28203094	1054	1059	serum	T031	UMLS:C0229671
28203094	1060	1066	miRNAs	T103	UMLS:C1101610
28203094	1078	1083	serum	T031	UMLS:C0229671
28203094	1084	1090	miRNAs	T103	UMLS:C1101610
28203094	1108	1113	mRNAs	T103	UMLS:C0035696
28203094	1125	1130	serum	T031	UMLS:C0229671
28203094	1131	1137	miRNAs	T103	UMLS:C1101610
28203094	1300	1305	serum	T031	UMLS:C0229671
28203094	1306	1311	miRNA	T103	UMLS:C1101610
28203094	1321	1325	mRNA	T103	UMLS:C0035696
28203094	1326	1338	interactions	T038	UMLS:C2753463